Pacira BioSciences, Inc.PCRXNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank86
3Y CAGR-5.3%
5Y CAGR+13.4%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-5.3%/yr
vs +43.6%/yr prior
5Y CAGR
+13.4%/yr
Recent deceleration
Acceleration
-48.9pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$119.13M+309.1%
2024$29.12M-81.2%
2023$154.59M+10.1%
2022$140.38M+23.2%
2021$113.95M+79.4%
2020$63.51M+106.5%
2019$30.75M-7.0%
2018$33.05M+412.1%
2017$-10.59M+40.7%
2016$-17.86M-